Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

NCT05964101 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Carcinoma, Squamous
Antineoplastic Agents

Interventions

DRUG: Nivolumab Injection [Opdivo]

Sponsor

The First Affiliated Hospital of Guangzhou Medical University